Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Adjuvant endocrine therapy (AET) significantly decreases the risk of breast cancer recurrence and mortality. Notwithstanding the demonstrated efficacy of AET, 31 –73% of breast cancer survivors do not persist w...

Source: BMC Cancer - July 11, 2018 Category: Cancer & Oncology Authors: Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard, Stephen K. Chia and Carolyn C. Gotay Tags: Research article Source Type: research